BNR Competitors & Alternatives
Compare Burning Rock Biotech Ltd with similar stocks in the same industry
Diagnostics & Research
BNR
Main Stock$8.90
Tradestie Score
44
Market Cap
$93.35M
Revenue Growth
-0.2%
Analyst Upside
-54.7%
Top Competitors
40 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OPK
Opko Health Inc.
|
$1.32
|
$1.23B | - | 50 | Compare |
|
NEO
NeoGenomics, Inc.
|
$15.29
|
$1.13B | - | 49 | Compare |
|
CDNA
CareDx, Inc.
|
$43.71
|
$798.40M | - | 45 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$16.55
|
$719.31M | - | 54 | Compare |
|
MYGN
Myriad Genetics Inc
|
$2.86
|
$719.23M | - | 55 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$23.21
|
$718.62M | - | 60 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$28.00
|
$667.77M | - | 57 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$12.66
|
$612.76M | - | 48 | Compare |
|
NBP
NBP
|
$1.60
|
$189.66M | - | 39 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$4.60
|
$85.47M | - | 53 | Compare |
More BNR Analysis
Data updated: Aug 02, 2026 | Industry: Diagnostics & Research (SIC 8071)
40 stocks in this industry